Lilly Endowment Inc

Avg. Two Year Performance

No purchase track record
(6%) Avg. Sale Return
(3%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(1%)(2%)(3%)(5%)(6%)
Sale Success Rate34 of 7532 of 7531 of 7526 of 7521 of 75
Drugs » Drug Manufacturers - Major

10% Owner:

Holdings: 109.41M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

($197.36M) Net Amount
Buy:0--
Sell:($197.36M)$200.48 - $233.63